Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Riboflavin (phosphate sodium)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 7 USDMF, 3 CEP/COS, 5 JDMF, 4 EU WC, 9 NDC API, 6 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 13 FDA Orange Book, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 14 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders, 20 Parenteral, 18 Solubilizers, 16 Taste Masking, 14 Film Formers & Plasticizers, 12 Chewable & Orodispersible Aids, 12 Topical, 11 Direct Compression, 9 Thickeners and Stabilizers, 8 Coating Systems & Additives, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 6 Co-Processed Excipients, 5 Emulsifying Agents, 4 Surfactant & Foaming Agents, 3 Granulation, 2 Coloring Agents, 1 Rheology Modifiers, 1 Controlled & Modified Release, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 2 News #PharmaBuzz

MARKET PLACE

10 APIs, 1 EXCIPIENTS

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
25/04/2025	Harman Finochem	India	HARMAN FINOCHEM LIMITED Mumbai IN	CEP 2010-254 - Rev 03	Riboflavin sodium phosphate hydrate	2025-03-28	Valid	Chemical		786
25/04/2025	Royal DSM	Netherlands	DSM Nutritional Products Ltd. Kaiseraugst CH	CEP 1999-123 - Rev 02	Riboflavin sodium phosphate hydrate	2023-10-04	Valid	Chemical		786

Riboflavin (phosphate Sodium)

Riboflavin (phosphate sodium)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers

7 USDMF

3 CEP/COS

5 JDMF

4 EU WC

9 NDC API

6 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers

13 FDA Orange Book

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

14 SPI Pharma

6 DKSH

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

6 Actylis

4 BASF

1 Bioplus Life Sciences

2 Finar

6 Gangwal Chemicals

1 Ingredion Pharma Solutions

3 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Nanjing Bold Chemical

3 Pluviaendo

1 Qualicaps

14 Roquette

8 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders

20 Parenteral

18 Solubilizers

16 Taste Masking

14 Film Formers & Plasticizers

12 Chewable & Orodispersible Aids

12 Topical

11 Direct Compression

9 Thickeners and Stabilizers

8 Coating Systems & Additives

8 Empty Capsules

7 Disintegrants & Superdisintegrants

6 Co-Processed Excipients

5 Emulsifying Agents

4 Surfactant & Foaming Agents

3 Granulation

2 Coloring Agents

1 Rheology Modifiers

1 Controlled & Modified Release

1 Soft Gelatin

1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow